The combinatorial treatment high throughput information driven paradigm alongside comprehensive CDC25 inhibitors are some of the most promising directions in halting cell cycle progression in cancer and should garner more focus with regards to clinical trials, even though they may be more difficult to design. Here, CDC25C is linked to cancer.